Technology · Biotechnology R&D expenditure
Iran does not yet allocate significant funds to biotechnology research and development: in 2026, spending is 20 $. This is due to the priority of traditional sectors — petrochemicals and agriculture, where the main investments are concentrated. The country ranks 77th in the world, but the number of startups in biopharmaceuticals has been growing in recent years, which could change the situation in the coming decade.
Data for 2026 · unit: $
Position
#77 / 197
Iran world ranking
Country position on the scale from last to first place for this indicator.
IR
#77
#197#1
Trend
Change over time
Change in indicator over the available period.
5
1990
10
2000
10
2010
20
2020
18
2025
20
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Iran stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Iran — how much?
Based on 2026 data — 20 $. This is rank #77 out of 197 countries.
What is Iran's rank by Biotechnology R&D expenditure?
Iran ranks #77 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Iran?
Over the available period the indicator changed from 5 to 20 $.